GSK’s consumer healthcare spinoff will launch on the London stock market on July 18 with a new name, a new CEO and around 10.3 billion pounds of debt.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,